Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma.
Publication
, Journal Article
Chen, M; Kirsch, DG
Published in: EClinicalMedicine
March 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
EClinicalMedicine
DOI
EISSN
2589-5370
Publication Date
March 2019
Volume
9
Start / End Page
5 / 6
Location
England
Related Subject Headings
- 4206 Public health
- 4203 Health services and systems
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Chen, M., & Kirsch, D. G. (2019). Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma. EClinicalMedicine, 9, 5–6. https://doi.org/10.1016/j.eclinm.2019.03.015
Chen, Mark, and David G. Kirsch. “Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma.” EClinicalMedicine 9 (March 2019): 5–6. https://doi.org/10.1016/j.eclinm.2019.03.015.
Chen M, Kirsch DG. Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma. EClinicalMedicine. 2019 Mar;9:5–6.
Chen, Mark, and David G. Kirsch. “Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma.” EClinicalMedicine, vol. 9, Mar. 2019, pp. 5–6. Pubmed, doi:10.1016/j.eclinm.2019.03.015.
Chen M, Kirsch DG. Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma. EClinicalMedicine. 2019 Mar;9:5–6.
Published In
EClinicalMedicine
DOI
EISSN
2589-5370
Publication Date
March 2019
Volume
9
Start / End Page
5 / 6
Location
England
Related Subject Headings
- 4206 Public health
- 4203 Health services and systems
- 3202 Clinical sciences